 | • レポートコード：MRC-IM30945 • 出版社/出版日：IMARC / 2023年3月 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥369,852 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥665,852 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2022年35億ドルであった世界の小児けいれん治療薬市場規模が2028年には45億ドルに達し、予測期間中（2023年-2028年）、年平均4.2％成長すると予測しています。当調査資料では、小児けいれん治療薬の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、治療薬クラス別（抗けいれん薬、副腎皮質ホルモン剤、その他）分析、治療薬タイプ別（ビガバトリン、副腎皮質刺激ホルモン、その他（フェーズIII））分析、剤形別（固体、液体）分析、投与経路別（経口、非経口、その他）分析、地域別（北米、アジア、欧州、中南米、中東/アフリカ）分析、要因・制約・機会、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当市場の主要企業には、H. Lundbeck A/S、Mallinckrodt plc、ORPHELIA Pharma、Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の小児けいれん治療薬市場規模：治療薬クラス別 - 抗けいれん薬の市場規模 - 副腎皮質ホルモン剤の市場規模 - その他治療薬クラスの市場規模 ・世界の小児けいれん治療薬市場規模：治療薬タイプ別 - ビガバトリンの市場規模 - 副腎皮質刺激ホルモンの市場規模 - その他（フェーズIII）治療薬タイプの市場規模 ・世界の小児けいれん治療薬市場規模：剤形別 - 固体治療薬の市場規模 - 液体治療薬の市場規模 ・世界の小児けいれん治療薬市場規模：投与経路別 - 経口投与の市場規模 - 非経口投与の市場規模 - その他投与経路の市場規模 ・世界の小児けいれん治療薬市場規模：地域別 - 北米の小児けいれん治療薬市場規模 - アジアの小児けいれん治療薬市場規模 - 欧州の小児けいれん治療薬市場規模 - 中南米の小児けいれん治療薬市場規模 - 中東/アフリカの小児けいれん治療薬市場規模 ・要因・制約・機会 ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global infantile spasms therapeutics market size reached US$ 3.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.2% during 2023-2028. The rising prevalence of seizures in infants, increasing health consciousness among the masses resulting in early diagnosis, and the growing number of product approvals and presence of strong pipelines drugs represent some of the key factors driving the market.
Infantile spasms therapeutics refer to the treatment procedures used for treating seizures or an epilepsy syndrome in young children, usually aged between four months and a year of age. An episode of spasm is characterized by the body stiffening suddenly, arms, legs, and head bending forward, the back arching, and short, subtle seizures. Infantile spasm can be caused by brain tumors, birth injuries, infection of the brain, and genetic changes. There are a number of therapeutic options that are available for infantile spams, including steroids, hormone therapy with corticotropin injection gel and glucocorticoids, as well as antiseizure medications. Infantile spasms therapeutics are more likely to provide sustained results if they are implemented within three weeks after the spasms occur, and treatment can be done by monotherapy or combination therapy. Infantile spasms are diagnosed by physical examination, neurological examination, MRI of the brain, and blood and urine examinations.
Infantile Spasms Therapeutics Market Trends:
The increasing prevalence of infantile spasms among newborn babies is a significant factor driving the growth of the market. This can be attributed to a considerable rise in the birth rates across the globe. In line with this, the growing number of product approvals and presence of strong pipelines drugs are impacting the market positively. Continual technological advancements in the treatment of infantile spasms, such as the introduction of seizure alert device for detecting seizures and alerting the caregivers, are providing an impetus to the market. Also, the widespread awareness regarding early diagnosis and treatment is enhancing the penetration rate of infantile spasm drugs, thereby fueling the market growth. However, various factors, such as lesser treatment success rates, high cost of treatment, strict regulations for drug approval, and the augmenting undiagnosed patient pool, are impeding the growth of the infantile spasms therapeutics market. On the contrary, favorable initiatives and programs conducted by the government and private organizations of several countries for promoting awareness regarding the medical condition is creating a positive market outlook. The market is further driven by the extensive research and development (R&D) activities conducted by the key market players focusing on the development of innovative drugs with higher success rates. Some of the other factors contributing to the market include the expanding healthcare expenditure, rising number of collaborations, partnerships and merger and acquisitions (M&As), rapid urbanization, and inflating disposable income levels.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global infantile spasms therapeutics market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on therapeutic class, drug type, dosage, route of administration, distribution channel, and end user.
Therapeutic Class Insights:
Anticonvulsants
Corticosteroids
Others
The report has provided a detailed breakup and analysis of the infantile spasms therapeutics market based on the therapeutic class. This includes anticonvulsants, corticosteroids, and others. According to the report, anticonvulsants represented the largest segment.
Drug Type Insights:
Vigabatrin
Adrenocorticotropic Hormone
Others (Phase III)
The report has provided a detailed breakup and analysis of the infantile spasms therapeutics market based on the drug type. This includes vigabatrin, adrenocorticotropic hormone, and others (phase III). According to the report, adrenocorticotropic hormone represented the largest segment.
Dosage Insights:
Solid
Liquid
The report has provided a detailed breakup and analysis of the infantile spasms therapeutics market based on the dosage. This includes solid and liquid. According to the report, liquid represented the largest segment.
Route of Administration Insights:
Oral
Parenteral
Others
The report has provided a detailed breakup and analysis of the infantile spasms therapeutics market based on the route of administration. This includes oral, parenteral, and others. According to the report, parenteral represented the largest segment.
Distribution Channel Insights:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
The report has provided a detailed breakup and analysis of the infantile spasms therapeutics market based on the route of administration. This includes hospital pharmacy, retail pharmacy, and online pharmacy. According to the report, hospital pharmacy represented the largest segment.
End User Insights:
Hospitals
Clinics
Others
A detailed breakup and analysis of the infantile spasms therapeutics market based on the distribution channel has also been provided in the report. This includes hospitals, clinics, and others. According to the report, hospitals accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for infantile spasms therapeutics. Some of the factors driving the North America infantile spasms therapeutics market include the presence of several key players, inflating disposable income levels, and the widespread awareness regarding early disease diagnosis and prevention.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global infantile spasms therapeutics market. Detailed profiles of all major companies have also been provided. Some of the companies covered include H. Lundbeck A/S, Mallinckrodt plc, ORPHELIA Pharma, Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global infantile spasms therapeutics market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global infantile spasms therapeutics market?
What are the key regional markets?
Which countries represent the most attractive infantile spasms therapeutics markets?
What is the breakup of the market based on the therapeutic class?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the dosage?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the end user?
What is the competitive structure of the global infantile spasms therapeutics market?
Who are the key players/companies in the global infantile spasms therapeutics market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Infantile Spasms Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Therapeutic Class
6.1 Anticonvulsants
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Corticosteroids
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Vigabatrin
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Adrenocorticotropic Hormone
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others (Phase III)
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Dosage
8.1 Solid
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Liquid
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Oral
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Parenteral
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Hospital Pharmacy
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Retail Pharmacy
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Online Pharmacy
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by End User
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Clinics
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Others
11.3.1 Market Trends
11.3.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 Drivers, Restraints, and Opportunities
13.1 Overview
13.2 Drivers
13.3 Restraints
13.4 Opportunities
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 H. Lundbeck A/S
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 Mallinckrodt plc
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 Financials
17.3.3 ORPHELIA Pharma
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.4 Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Figure 1: Global: Infantile Spasms Therapeutics Market: Major Drivers and ChallengesFigure 2: Global: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Infantile Spasms Therapeutics Market: Breakup by Therapeutic Class (in %), 2022
Figure 5: Global: Infantile Spasms Therapeutics Market: Breakup by Drug Type (in %), 2022
Figure 6: Global: Infantile Spasms Therapeutics Market: Breakup by Dosage (in %), 2022
Figure 7: Global: Infantile Spasms Therapeutics Market: Breakup by Route of Administration (in %), 2022
Figure 8: Global: Infantile Spasms Therapeutics Market: Breakup by Distribution Channel (in %), 2022
Figure 9: Global: Infantile Spasms Therapeutics Market: Breakup by End User (in %), 2022
Figure 10: Global: Infantile Spasms Therapeutics Market: Breakup by Region (in %), 2022
Figure 11: Global: Infantile Spasms Therapeutics (Anticonvulsants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Infantile Spasms Therapeutics (Anticonvulsants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Infantile Spasms Therapeutics (Corticosteroids) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Infantile Spasms Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Infantile Spasms Therapeutics (Other Therapeutic Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Infantile Spasms Therapeutics (Other Therapeutic Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Infantile Spasms Therapeutics (Vigabatrin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Infantile Spasms Therapeutics (Vigabatrin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Infantile Spasms Therapeutics (Adrenocorticotropic Hormone) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Infantile Spasms Therapeutics (Adrenocorticotropic Hormone) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Infantile Spasms Therapeutics (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Infantile Spasms Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Infantile Spasms Therapeutics (Solid) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Infantile Spasms Therapeutics (Solid) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Infantile Spasms Therapeutics (Liquid) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Infantile Spasms Therapeutics (Liquid) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Infantile Spasms Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Infantile Spasms Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Infantile Spasms Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Infantile Spasms Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Infantile Spasms Therapeutics (Other Routes of Administration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Infantile Spasms Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Infantile Spasms Therapeutics (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Infantile Spasms Therapeutics (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Infantile Spasms Therapeutics (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Infantile Spasms Therapeutics (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Infantile Spasms Therapeutics (Online Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Infantile Spasms Therapeutics (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Infantile Spasms Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Infantile Spasms Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Infantile Spasms Therapeutics (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Infantile Spasms Therapeutics (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: Infantile Spasms Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: Infantile Spasms Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: North America: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: North America: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: United States: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: United States: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Canada: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Canada: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Asia-Pacific: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Asia-Pacific: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: China: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: China: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Japan: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Japan: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: India: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: India: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: South Korea: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: South Korea: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Australia: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Australia: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Indonesia: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Indonesia: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Europe: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Europe: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Germany: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Germany: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: France: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: France: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: United Kingdom: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: United Kingdom: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Italy: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Italy: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Spain: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Spain: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Russia: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Russia: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Latin America: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Latin America: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Brazil: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Brazil: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Mexico: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Mexico: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Others: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Others: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Middle East and Africa: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Middle East and Africa: Infantile Spasms Therapeutics Market: Breakup by Country (in %), 2022
Figure 93: Middle East and Africa: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Global: Infantile Spasms Therapeutics Industry: Drivers, Restraints, and Opportunities
Figure 95: Global: Infantile Spasms Therapeutics Industry: Value Chain Analysis
Figure 96: Global: Infantile Spasms Therapeutics Industry: Porter's Five Forces Analysis